This trial is designed to evaluate QPI-1002 versus placebo for the prevention of Major Adverse Kidney Events (MAKE) in subjects at high risk for acute kidney injury following cardiac surgery. Half of the participants will receive QPI-1002 while the other half will receive placebo.
This is a randomized, double-blind, placebo-controlled, Phase 3 trial to evaluate QPI-1002 versus placebo for the prevention of Major Adverse Kidney Events in subjects at high risk for acute kidney injury following cardiac surgery. Subjects will be dosed with active drug or placebo after the completion of cardiovascular surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
1,043
IV injection
isotonic saline
Proportion of subjects through day 90 who develop major adverse kidney events
Time frame: Baseline through day 90
Proportion of subjects developing AKI overall by modified AKIN criteria within 5 days post-surgery
Time frame: Baseline through day 5
Renal function as estimated by glomerular filtration rate
Time frame: Baseline through Day 90
Proportion of subjects who die or initiate dialysis through day 90
Time frame: Baseline through day 90
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Alabama at Birmingham Hospital
Birmingham, Alabama, United States
Keck Hospital of USC
Los Angeles, California, United States
Cedar-Sinai Heart Institute
Los Angeles, California, United States
Ronald Regan UCLA Medical Center
Los Angeles, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
River City Clinical Research
Jacksonville, Florida, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Emory Saint Joseph's Hospital
Atlanta, Georgia, United States
Northwestern University
Evanston, Illinois, United States
Indiana/ Ohio Heart, a division of Luthern Medical Group, LLC
Fort Wayne, Indiana, United States
...and 94 more locations